The challenge now is to make sure access and coverage, and the policies that expand them, catch up." Read more: USC Schaeffer Institute To view or add a comment, sign in India's Pharma Sector Pivots to Specialty Drugs in 2026 The Indian pharmaceutical market is undergoing a strategic shift
Its mechanisms include: Improving insulin sensitivity Reducing hepatic glucose production Slowing gastric emptying Enhancing satiety Supporting sustained weight reduction Lower insulin levels reduce ovarian stimulation of androgen production
Usefulness of continuous glucose monitoring for the diagnosis of hypoglycemia after a gastric bypass in a patient previously treated for type 2 diabetes
Nanoparticle and Lipid-Based Carriers Nanoparticles and lipid-based carriers may encapsulate peptides, shielding them from proteolytic enzymes and enhancing uptake across epithelial barriers
Its in Phase 2b/3 trials for type 2 diabetes and weight management and weight-related comorbidities
Frequently employed cabergoline doses range from 0.5 to 3.5 mg per week (maximum FDA approved dose is 2 mg weekly), bromocriptine doses range from 2.5 to 15 mg per day and quinagolide doses range from 75 to 300 g per day
